Drug Profile
Fipamezole
Alternative Names: BVF-025; JP-1730Latest Information Update: 05 Nov 2023
Price :
$50
*
At a glance
- Originator Juvantia Pharma
- Developer Juvantia Pharma; Santhera Pharmaceuticals
- Class Antiparkinsonians; Imidazoles; Indans; Small molecules
- Mechanism of Action Alpha 2 adrenergic receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
- Available For Licensing Yes - Parkinson's disease
Highest Development Phases
- Discontinued Parkinson's disease